A Study to Find Out if the New Ebola Vaccine is Safe and Stimulates Immunity That Might Protect Adults in Kilifi, Kenya.

Condition:   Ebola Virus DiseaseIntervention:   Biological: VSV-ZEBOVSponsors:   University of Oxford;   World Health Organization;   Wellcome Trust;   Institute of Tropical Medicine, University of Tuebingen;   Albert Schweitzer Hospital;   Philipps University Marburg Medical Center;   Universitätsklinikum Hamburg-Eppendorf;   University Hospital, GenevaNot yet recruiting - verified November 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials